Friedrich-Alexander-Universität Erlangen-Nürnberg
🇩🇪Germany
Clinical Trials
14
Active:2
Completed:9
Trial Phases
4 Phases
Phase 1:1
Phase 2:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (66.7%)Phase 1
1 (11.1%)Phase 2
1 (11.1%)Phase 4
1 (11.1%)Detection of Aortic Stenosis With Smartphone Auscultation Using Machine Learning (HEARTBEAT-Pilot)
Recruiting
- Conditions
- Aortic Valve Stenosis
- First Posted Date
- 2024-05-08
- Last Posted Date
- 2024-05-08
- Target Recruit Count
- 100
- Registration Number
- NCT06404437
- Locations
- 🇩🇪
Deparment of Medicine 2 - Cardiology and Angiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
Contrast-enhanced Ultrasound in Patients With Crohn´s Disease and Food Allergy
Completed
- Conditions
- Crohn DiseaseFood Allergy
- First Posted Date
- 2023-03-15
- Last Posted Date
- 2023-03-15
- Target Recruit Count
- 48
- Registration Number
- NCT05768971
Fistula-in-ano in Infants and Children
Not Applicable
Recruiting
- Conditions
- Fistula in Ano
- First Posted Date
- 2022-12-28
- Last Posted Date
- 2025-09-08
- Target Recruit Count
- 20
- Registration Number
- NCT05666609
- Locations
- 🇩🇪
Friedrich-Alexander-Universität Erlangen-Nürnberg, Pediatric Surgery, Erlangen, Bavaria, Germany
Effect of Postoperative Additive Systemic Steroids in CRSwNP
Phase 4
Completed
- Conditions
- Sinusitis, Chronic
- Interventions
- Drug: Systemic Steroid (Prednisolone)Other: Placebo
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2021-06-07
- Target Recruit Count
- 106
- Registration Number
- NCT04915456
Sacral Neuromodulation in Children and Adolescents
Not Applicable
Completed
- Conditions
- Anorectal MalformationsSacral DysgenesisChronic Constipation With OverflowEncopresis With Constipation and Overflow IncontinenceHirschsprung's Disease
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2025-09-08
- Target Recruit Count
- 48
- Registration Number
- NCT04713085
- Locations
- 🇩🇪
Friedrich-Alexander-Universität Erlangen-Nürnberg, Pediatric Surgery, Erlangen, Bavaria, Germany
- Prev
- 1
- 2
- Next
News
Stereotactic Ablative Radiotherapy Shows Promise in Pancreatic Cancer Treatment, While Phase 3 Trial Questions Chemoradiation Benefits
Stereotactic ablative radiotherapy (SAbR) combined with neoadjuvant chemotherapy improved pathologic outcomes and locoregional recurrence-free survival in pancreatic cancer patients, particularly those with arterial involvement.